BioCentury | Nov 15, 2010
Strategy

Lilly avid for diagnostics

...neurology drugs sales force will sell florbetapir if it is approved. Avid also is developing AV-133...
BioCentury | Oct 29, 2007
Emerging Company Profile

Avid: Quick and early

...AG, a unit of Bayer AG (FSE:BAY; BAY, Leverkusen, Germany). In the PD/DLB PET program, AV-133...
BioCentury | Oct 8, 2007
Clinical News

AV-133: Phase I started

...a U.S. Phase I trial in 30 patients. Avid Radiopharmaceuticals Inc. , Philadelphia, Penn. Product: AV-133...
Items per page:
1 - 3 of 3